Home / Stock ratings / COO
Stock rating · Ophthalmic Goods
The Cooper Companies, Inc. (COO) Stock Rating & Analysis
As of October 30, 2026, MELANY rates The Cooper Companies, Inc. 64 out of 100 (Hold). Its highest factor score is earnings track record at 81, and its lowest is price momentum at 35.
MELANY ratingRated 2026-10-30COO · composite score
About The Cooper Companies, Inc.
CooperCompanies is among the largest US eyecare companies and operates in two segments. CooperVision is a pure-play contact lens business offering spherical, multifocal, and toric lenses plus one of the most comprehensive specialty lens portfolios in the world; with brands including Proclear, Biofinity, MyDay, and Clariti, it holds roughly a fourth of the US contact lens market. CooperSurgical, founded in 1990, comprises equipment for reproductive care, fertility, and women's care.
Rating as of 2026-10-30 · this is a dated snapshot; the live rating and the live price are in the app (the rating is part of Pro, free for 30 days).
Why COO scores 64/100
COO's 8 factor scores run from 35 to 81, and 4 of them sit above its composite of 64. Here is how COO breaks down.
Whether the price looks cheap or expensive against earnings, growth, and peers.
- P/E 20.5x vs sector 22.0x median
- Forward P/E 12.7x, earnings growth accelerating
- PEG ratio 0.57 (< 1 = undervalued)
Margins, returns on capital, and balance-sheet strength.
- Gross margin 66%
Direction and relative strength of the recent share-price trend.
History of beating or missing estimates, and where estimates are heading.
- Beat EPS estimates 4 of last 4 quarters
- Avg EPS beat +6%
What Wall Street price targets and revisions are signalling.
- Institutional net buying +3.1%
Near-term events that could move the stock.
- Earnings in 21 days
Upside weighed against volatility and drawdown risk.
How the current rate and market regime suits this kind of company.
Key risks for COO
- Weak price momentum, trend not yet confirmed, may need more time to set up
- Performance partly driven by Healthcare sector, rotation away from this theme would hurt
Sector and theme context
The Cooper Companies, Inc. sits in the Healthcare sector theme, which MELANY currently rates 99/100 for strength. Theme strength feeds COO's momentum and catalyst factors above.
Tracking COO
The Cooper Companies, Inc. rates Hold right now, so MELANY is not flagging a fresh entry. Add COO to a watchlist in the app to follow its rating; an alert the moment it changes is part of Pro, free for 30 days.
How MELANY rates COO
MELANY is a rules-based engine that scores every stock from 0 to 100 across eight weighted factors, then re-scores as new price, earnings, and fundamental data arrive. The Cooper Companies, Inc.'s 64/100 reflects mature factor weighting for its profile.
Ratings are algorithmic and change with the data. They are research and education, not personalized investment advice.
Frequently asked questions about COO
Is The Cooper Companies, Inc. (COO) a buy?
As of 2026-10-30, MELANY rated The Cooper Companies, Inc. Hold with a composite score of 64/100. That is a dated snapshot, not the live rating, and it is an algorithmic reading built from eight factors rather than personalized investment advice. Review the factor breakdown above and the disclaimer below before making any decision.
Should I buy The Cooper Companies, Inc. stock?
That decision is yours; Market Eyes Live does not give buy or sell advice. What the data says: MELANY rates The Cooper Companies, Inc. (COO) Hold with a composite of 64/100 as of 2026-10-30. The factor breakdown above shows what is driving that, which is a better basis for a decision than any one-word verdict.
What is the COO stock price forecast?
MELANY does not publish price targets or forecasts for COO. Predicting a future price is exactly the kind of false precision the confidence framework avoids. Instead it scores today's setup, 64/100 across eight factors for The Cooper Companies, Inc., and re-scores automatically as new price, earnings, and fundamental data arrive. What it does read for COO as of 2026-10-30: its analyst sentiment factor is 63/100 (Institutional net buying +3.1%), and its price momentum factor is 35/100.
Is COO stock overvalued or undervalued?
MELANY's valuation factor currently reads 72/100 for The Cooper Companies, Inc., where a higher score means the price looks more attractive on that measure. Scores in the 70s and above read as attractively priced, the mid range as roughly fair, and low scores as stretched. The factor breakdown above shows what drives COO's read.
What price should I buy COO at?
MELANY is not flagging a fresh entry for COO at its current Hold rating, so there is no entry zone to publish right now. Add COO to a watchlist in the app to follow it; an alert the moment the rating changes is part of Pro, free for 30 days.
What are the risks of buying COO stock?
The top risks MELANY currently flags for The Cooper Companies, Inc.: Weak price momentum, trend not yet confirmed, may need more time to set up; Performance partly driven by Healthcare sector, rotation away from this theme would hurt. The rating on this page already weighs these against the bullish factors; see the risk-adjusted profile score in the breakdown above.
Is The Cooper Companies, Inc. a good long-term investment?
For long-term durability the two factors that matter most are business quality, which MELANY scores 61/100 for The Cooper Companies, Inc., and earnings track record, at 81/100. The 64/100 composite blends those with six shorter-horizon factors. Durable quality at a fair price is the long-term case to test; this is research, not personalized investment advice.
Will COO stock go up?
Nobody can promise a stock's direction, and Market Eyes Live does not predict prices. The measurable part: MELANY's price momentum factor reads 35/100 for COO right now, and the catalyst setup factor tracks whether near-term events could move it. Both re-score automatically as the data changes.
How current is this COO rating?
The rating on this page is a snapshot of MELANY's read as of 2026-10-30, and the score is not recomputed on this page. MELANY re-scores COO as new price, earnings, and fundamental data arrive; the current rating and the live price are in the app (the rating is part of Pro, free for 30 days).
How this rating works
Market Eyes Live
Every rating graded in public, COO included
MELANY scores more than 11,000 U.S. stocks and ETFs, PRISM ranks conviction and APEX writes the plan with one entry zone. Free to start on iOS and the web.